Alternative pathways of neural control of the immune process

Annals of the New York Academy of Sciences

Volumn 840, Issue , 1998, Pages 301-316

  Reichlin, Seymour ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; GLIA CELL; HEAD INJURY; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; NERVE FIBER; NEUROBLASTOMA; NEUROIMMUNOLOGY; NEUROMODULATION; NONHUMAN; RAT; SENSORY NERVE CELL; STROKE; SUPERIOR SAGITTAL SINUS; SYMPATHETIC NERVE;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0032077552     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09570.x     Document Type: Conference Paper

References (60)

1. ADER, R., D. L. FELTEN, N. COHEN, Eds. 1991. Psychoneuroimmunology, Second Ed. Academic Press. San Diego.
2. COUSINS, N. 1979. Anatomy of an Illness as Perceived by the Patient. Norton. New York.
3. KIECOLT-GLASER, J. K. & R. GLASER. 1991. Stress and immune function in humans. In Psychoneuroimmunology, 2nd Edit. Ader et al., Eds.: 849-867.
4. LOCKE, S. & M. HORNIG-ROHAN. 1983. Mind and Immunity. Institute for the Advancement of Health. New York.
5. COLE, S. W., M. E. KEMENY, S. E. TAYLOR, B. R. VISSCHER & J. L. FAHEY. 1996. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom. Med. 58: 219-231.
6. LEWIS, C. E., C. O'SULLIVAN & J. BARRACLOUGH, Eds. 1994. The Psychoimmunology of Cancer. Oxford Medical Publications. New York.
7. IRWIN, M. 1994. Stress-induced immune suppression. Ann. N. Y. Acad. Sci. 741: 203-217.
8. WEISS, J. M., S. K. SUNDAR & K. J. BECKER. 1989. Neuroimmune Networks: Physiology and Diseases. Alan R. Liss. pp. 193-206.
9. ADER, R. & N. COHEN. 1991. The influence of conditioning on immune responses. In Psychoneuroimmunology, 2nd Edit. Academic Press. New York. pp. 611-646.
10. ROSZMAN, T. L. & VV. H. BROOKS. 1985. Neural modulation of immune function. J. Neuroimmunomod. 10: 59-69.
11. MACLEAN, D. & S. REICHLIN. 1981. Neuroendocrinology and the immune process. In Psychoneuroimmunology. R. Ader. Ed.: 475-520. Academic Press. New York.
12. MADDEN, K. S., V. M. SANDERS & D. L. FELTEN. 1995. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Ann. Rev. Pharmacol. Toxicol. 35: 417-448.
13. REICHLIN, S. 1995. Endocrine-Immune Interaction. In Endocrinology. L J. DeGroot, Ed.: 2964-3012. W. B. Saunders, Co. Philadelphia, PA.
14. CHROUSOS, G. P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332:135-1362.
15. BANKS, W. A., A. J.KASTLM & R. D.BROADWELL. 1995. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2: 241-248.
16. BODNAR, R. J., G. W. PASTERNAK, D. MANN, R. PAUL, R. WARREN & D. B. DONNER. 1989. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Res. 15: 6280-6284.
17. KAKUCSKA, I, Y. QI, B. D. CLARK & R. M. LECHAN. 1993. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133: 815-821.
18. BOOMER S., D. HUBER, I. HEID & A. FONTANA. 1991. Human glioblastoma cell derived transforming growth factor-beta 2: Evidence for secretion of both high and low molecular weight biologically active forms. J. Neuroimmunol. 34: 33-42.
19. KOSSMANN, T., V. H. HANS, H. G. LMHOF, R. STOCKER P. GROB, O. TRENTZ & C. MORGANTI-KOSSMAN. 1995. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4:311-317.
20. TARKOWSKI, E., L. ROSENGREN, C. BLOMSTRAND, C. WIKKELSO, C. JENSEN, S. EKHOLM & A. TARKOWSKI. 1995. Early intrathecal production of interleukin-6 predicts the size of brain lesions in stroke. Stroke 26:1393-1398.
21. FAGGIONI, R., F. BENIGNI & P. GHEZZI. 1995. Proinflammatory cytokines as pathogenetic mediators in the central nervous system: brain-periphery connections. Neuroimmunomodulation 2: 2-15.
22. CSERR, H. F. & P. M. KNOPF. 1992. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 13: 507-512.
23. HOPKINS, S. J. & N. J. ROTHWELL. 1995. Cytokines and the nervous system I: Expression and recognition. Trends Neurosci. 18: 83-88.
24. LECHAN, R. M., R. TONI, B. D. CLARK, J. G. CANNON, A. R. SHAW, C. A. DINARELLO & S. REICHUN. 1990. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 514: 135-140.
25. RINGHEIM, G. E., K. L. BURGHER & J. A. HEROUX. 1995. Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol. 63:113-123.
26. BREDER, C. D., M. TSUJIMOTO, Y. TERANO, D. W. SCOTT & C. B. SAFER. 1993 Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 337: 543-567.
27. TARLOW, M. J., R. JENKINS, S. D. COMIS, M. P. OSBORNE, S. STEPHENS, P. STANLEY & J. CROCKER. 1993. Ependymal cells of the choroid plexus express tumour necrosis factora. Neuropath. Appl. Neurobiol. 19: 324-328.
28. VAN DAM, A. M., H. E. DE VRIES, J. KUIPER, F. J. ZILJLSTRA, A. G. DE BOER, F. J. TILDERS & F. BERKENBOSCH. 1996. Interleukin-1 receptors on rat brain endothelial cells: A role in neuroimmune interaction? FASEB J. 10:351-356.
29. LEE, S. C., W. LIU, D. W. DICKSON, C. F. BROSMAN & J. W. BERMAN. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150: 2659-2667.
30. CHAD, C. C., S. Hu, W. S. SHENG & P. K. PETERSON. 1995. Tumor necrosis factor-alpha production by human fetal microglial cells: Regulation by other cytokines. Dev. Neurosci. 17: 97-105.
31. BENVENISTE, E. N. 1994. Cytokine circuits in the brain. Implications for AIDS dementia complex. Res. Publ. ANRMD 72: 71-88.
32. ERICSSON, A., C. Liu, R. P. HART & P. E. SAWCHENKO. 1995. Type 1 interleukin-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol: 361: 681-698.
33. KRUGER, M. J., W. KOZAK, L. R. LEON, D. SOSZNSKI & C. A. CONN. 1995. Cytokines and fever. Neuroimmunomodulation 2:216-223.
34. ANDERSSON, P. B., V. H. PERRY & S. GORDON. 1992. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J. Exp. Med. 176: 255-259.
35. DE SIMONI, M. G., M. SIRONI, A. DE LUIGI, A. MANFRIDI & P. GHEZZI. 1993. Intracerebroventricular injection of interleukin-1 induces high circulating levels of interleukin-6. J. Exp. Med. 171:1773-1778.
36. 35a. DE SIMONI, M. G., A. DE LUIGI, L. GEMMA, M. SIRONI, A. MANFRIDI & P. GHEZZI. 1993. Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 265: R739-742.
37. GOTTSCHALL, P. E., G. KOMAKI & A. ARIMURA. 1992. Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide. Neuroendocrinology 56: 935-938.
38. MCGEER, P. L. & E. G. McGEER. 1995. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:195-218.
39. MINAMI, M., Y. KURAISHI, T. YAMAGUCHI, S. NAKAI, Y. HIRAI & M. SATOH. 1991. Immobilization stress induces interleukin-1 beta messenger RNA in rat brain. Neurosci. Lett. 123: 254-256.
40. DERIJK, R. H., A. BOELEN, F. J. TILDERS & F. BERKENBOSCH. 1994. Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19: 155-163.
41. SCHETTINI, G., M. GRLMALDI, P. NAVARRA, G POZZOLI, S. REICHLIN & P. PREZIOSI. 1994. Regulation of interleukin 6 production by cAMP protein kinase-A pathway in rat cortical astrocytes. Pharmacol. Res. 30:13-24.
42. GOTTSCHALL, P. E., I. TATSUNO & A. ARIMURA. 1994. Regulation of interleukin-6 (IL-6) secretion in primary cultured astrocytes: Synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637: 197-203.
43. FIEBICH, B. L., K. BIBER, K. GYUFKO, M. BERGER, J. BAUER & D. VAN CALKER. 1996. Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J. Neurochem. 66:1426-1431.
44. DE SIMOM, M. G., A. DE LUIGI, L. GEMMA, M SIRO.MI, A. MANFRIDI & P. GHEZZI. 1993. Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 265: R739-R742.
45. ROMERO, L. I., I. KAKUCSKA, R. M. LECHAN & S REICHUN. 1996. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1β in rats. Am. J. Physiol. 270: R518-R524.
46. DE SLMONI, M. G., R. DEL BO, A. DE LUIGI, S. SIMARD & G. FORLONI. 1995. Central endotoxin induces different patterns of interleukin (IL)-1 beta and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology 136: 897-902.
47. SUNDAR, S. K., M. A. CIERPIAL, C. KILTS, J. C. RITCHIE & J. M. WEISS. 1990. Brain IL-1 induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin releasing factor. J. Neurosci. 10: 3701-3706.
48. IRWIN, M. 1994. Stress-induced immune suppression: Role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv. Neuroimmunol. 4: 29-47.
49. VREDEVOE, D. L., D. K. MOSER, X-H. GAN & B. BONAVIDA. 1995. Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: Relationship to norepinephrine. Neuroimmunomodulation 2:16-24.
50. TAKAKI, A., Q-H. HUANG, A. SOMOGYVÁRI-VIGH & A. ARIMURA. 1994. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1: 335-342.
51. WEISS, J. M., N. QUAN & S. K. SUNDAR:-1994, Widespread activation and consequences of interleukin-1 in the brain. Ann. N.Y. Acad. Sci. 741:338-357.
52. HUANG, O. H., A. TAKAKI & A. ARIMURA. 1997. Central noradrenergic system modulates plasma interleukin-6 production by peripheral interleukin-1. Am. J. Physiol. 273(2 Pt 2): R731-R738.
53. IRWIN, M., R. L. HAUGER, M. BROWN & K. T. BRTTTON. 1988. CRF activates autonomic nervous system and reduced natural killer cytotoxicity. Am. J. Physiol. 255 R744-R747.
54. DUNN, A. J. & J. WELCH. 1991. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J. Neurochem. 57:1615-1622.
55. GOODMAN, J. C., C. S. ROBERTSON, R. G. GROSSMAN & R. K. NARAYAN. 1990. Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30:213-217.
56. CHEN, G. J. & R. R. WATSON. 1991. Modulation of tumor necrosis factor and gamma-interferon production by cocaine and morphine in aging mice infected with LP-BM5, a murine retrovirus. J. Leuk. Biol. 50:349-355.
57. URBASCHEK, B., K-P. B. BECKER, R. DrrrER & R. URASCHEK. 1985. Quantification of endotoxin and sample-related interferences in human plasma and cerebrospinal fluid by using a kinetic limulus amoebocyte lysate microtiter test. In Microbiology-1985, L. Leive, Ed.: 39-13. American Society of Microbiology, Washington, DC.
58. NILSSON, C., M. LINDVALL-AXELSSON & C. OWMAN. 1992. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res. Rev. 17: 109-138.
59. NATHANSON, J. A. & L. L. CHUN. 1989. Immunological function of the blood-cerebrospinal fluid barrier. Proc. Natl. Acad. Sci. USA 86:1684-1688.
60. MCGEER, P. L. & E. G. MCGEER. 1995. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:195-218.